Vir Biotechnology, Inc.
VIR
$6.12
-$0.17-2.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.82% | -30.78% | 28.95% | 53.67% | -14.14% |
| Total Depreciation and Amortization | -35.57% | -36.85% | -10.28% | -19.88% | 129.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.45% | -33.17% | 9.26% | 2,792.05% | 632.45% |
| Change in Net Operating Assets | 48.09% | 158.91% | 99.07% | -865.94% | -125.23% |
| Cash from Operations | 18.80% | -10.04% | 80.00% | 13.03% | -407.26% |
| Capital Expenditure | -56.81% | 36.56% | 92.96% | 72.74% | 87.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 236.23% | 318.96% | -11.63% | -71.64% | 26.51% |
| Cash from Investing | 234.28% | 301.18% | -8.12% | -71.02% | 31.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.00% | 39.39% | -1.47% | -4.55% | 359.74% |
| Issuance of Common Stock | -29.26% | -79.30% | -10.04% | -90.43% | -15.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 42.51% | -- | -- | -- | -- |
| Cash from Financing | -24.82% | -88.81% | -7.46% | -93.52% | -16.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.76% | 75.36% | 187.77% | -218.70% | -81.95% |